TTX Blocks Baclofen-induced Phase Shifts of the Mammalian Circadian Pacemaker in Vitro

Document Type

Article

Publication Date

9-1999

Abstract

The mammalian circadian pacemaker, located in the suprachiasmatic nucleus (SCN), expresses 24-h rhythms when isolated in vitro. The GABAA agonist, muscimol, induces phase advances during the mid-subjective day, while the GABAB agonist, baclofen, induces both daytime phase advances and nighttime phase delays. Here, we present evidence that tetrodotoxin (TTX) completely blocks baclofen-induced phase shifts in vitro, but does not block in vitro phase advances induced by muscimol. These results suggest that GABAA, but not GABAB, receptors are located on SCN pacemaker cells.

Files over 3MB may be slow to open. For best results, right-click and select "save as..."

Share

COinS